, , . . , . . 10 , 10% 3~4 . . , , . 2 , 40, 60 . . . . . , , . . . . . D . , , , . , , , . , . 4mm , , . , . 30~40 . 2 , 3 . , . , . , 2L , , . : 0
60 . [=] 60 . , . 60 3 1 “ ” . 35 . 10 , , . 60 13 . 1. 60 40% . . () () . , , , , . 80% . 10 . , . 5 ( 131) . 2. 60 . 50% 61 . 68. . , , () . 3. . 60 . . . 4. 60 . , . , . . . 5. 60 … [+274 chars]
2022 6 30 ‘’ [ ] 3 ( ) . (NTCP) NTCP- 3 , (Nature) . , NTCP B , D . (Glyco-protein) , (NTCP = Sodium taurocholate cotransporting polypeptide) NTCP B (HBV) D (HDV) . NTCP 3 . NTCP , (Cryo… [+130 chars]
Copyright . All rights reserved.
= (·· ) . 30 , ·· . ' (Metabolic Brain Disease)' . , . 2 . (UniSA) ·· . (Tau protein) 'pR5 ' 30 , ·· ··· . 1.5( 80) (30) . , . pR5 , . . " pR5 , " " " . " . ·· , , " .
[ ] , , . (NTCP) NTCP- 3 , ‘’ 6 30( ) 13 . NTCP , (Cryo-EM) NTCP . B , . (Unmet Needs) . “ NTCP , , ” .
. 12~17, 20 . , . . , . ''. ? 10 . , 15 50% . , . , , , , . , . . , , , , , . . , . , . , . , . . . . . , . , .
. , . , 1 , . , . . ‘ ’ , 98% 1 , . . . . . , . . , . , , , . , 10 12 . ©
' ' . . . , . 10 7 , 45% . 75% . , . . , . . , . , , . 10~30% . . . . . 10.8% . © (cancer answer) 0